Physician

Mel F. Roca, M.D.

According to 2025 Medicare claims, Mel Roca, M.D. (NPI: 1841427564) practices family practice in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is ALEGENT CREIGHTON CLINIC (NPI: 1598811069; TIN: 470765154) and primary practice location at 51501-3359. Roca is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Roca's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 305 traditional Medicare patients, billed 2,423 HCPCS/CPT codes, and received $102,486 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,907 prescription claims across 648 beneficiaries totaling $1,093,639 in drug costs, led by Eliquis (Apixaban). DME data shows 382 claims. Open Payments data shows 154 records totaling $3,207. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $323,260 to $1,093,639. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,927 and ending at $20,019.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	451	6,914	$89,253
2016	545	6,738	$122,599
2017	502	11,757	$109,755
2018	517	10,200	$119,380
2019	424	6,747	$106,053
2020	332	5,565	$77,611
2021	346	4,514	$84,181
2022	334	2,099	$82,229
2023	333	2,816	$93,703
2024	305	2,423	$102,486

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	6,618	$323,260
2016	499	6,979	$337,609
2017	503	7,054	$387,115
2018	550	7,540	$507,974
2019	526	7,883	$643,476
2020	464	8,030	$566,683
2021	490	7,403	$674,729
2022	559	7,897	$830,829
2023	668	8,394	$1,072,019
2024	648	9,907	$1,093,639

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	37	317	$10,506
2016	42	383	$10,736
2017	54	383	$7,611
2018	69	446	$9,604
2019	64	494	$20,058
2020	84	338	$18,248
2021	62	412	$21,152
2022	63	394	$21,971
2023	52	283	$8,035
2024	95	382	$22,091

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	121	121	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	233	459	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	116	156	$50
G0008	Administration of influenza virus vaccine	70	75	$30
36415	Insertion of needle into vein for collection of blood sample	197	329	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	129	5,199	$104,572
Farxiga	Dapagliflozin Propanediol	95	4,885	$94,483
Mounjaro	Tirzepatide	75	2,212	$81,104
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	92	3,810	$80,608
Jardiance	Empagliflozin	63	4,175	$80,105

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	13	$9,777
A7031	Face mask interface, replacement for full face mask, each	N	11	38	$2,562
A7030	Full face mask used with positive airway pressure device, each	N	11	32	$2,377
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	22	$1,385
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	43	$1,188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	154	$3,207	AIMMUNE THERAPEUTICS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mel F. Roca, M.D.?

Tedicare shows public-source Medicare data for Mel F. Roca, M.D. (NPI 1841427564), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mel F. Roca, M.D. have ACO affiliation data?

Mel F. Roca, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Mel F. Roca, M.D.?

Mel F. Roca, M.D. is linked to ALEGENT CREIGHTON CLINIC (billing NPI 1598811069) in the available physician profile data.

Does Mel F. Roca, M.D. have Open Payments data?

Mel F. Roca, M.D. has 154 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.